RecruitingNot applicableNCT06132750
A 5-year Natural History Study in LAMA2-related Muscular Dystrophy and SELENON-related Myopathy.
Studying Laminin subunit alpha 2-related muscular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Radboud University Medical Center
- Principal Investigator
- Ilse de Laat
- Intervention
- No intervention(other)
- Enrollment
- 40 enrolled
- Eligibility
- 1-100 years · All sexes
- Timeline
- 2023 – 2026
Study locations (1)
- Radboudumc, Nijmegen, Gelderland, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06132750 on ClinicalTrials.gov